In Reply: “On Insulin Kinetics Following High-Dose Insulin Therapy, and When to Stop Therapy”

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Corcoran JN, Jacoby KJ, Olives TD, Bangh SA, Cole JB. Persistent hyperinsulinemia following high-dose insulin therapy: a case report. J Med Toxicol. 2020;16:465–9.

    Article  Google Scholar 

  2. 2.

    Rabkin R, Ryan MP, Duckworth WC. The renal metabolism of insulin. Diabetologia. 1984;27:351–7.

    CAS  Article  Google Scholar 

  3. 3.

    Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol-Endocrinol Metab. 1983;244:E517–27.

    CAS  Article  Google Scholar 

  4. 4.

    Rabkin R, Simon NM, Steiner S, Colwell JA (2010) Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 1970; 282:182–187.

  5. 5.

    Katz AI, Rubenstein AH. Metabolism of proinsulin, insulin, and C-peptide in the rat. J Clin Invest. 1973;52:1113–21.

    CAS  Article  Google Scholar 

  6. 6.

    Waldhäusl WK, Bratusch-Marrain PR, Vierhapper H, Nowotny P. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man. Metabolism. 1983;32:478–86.

    Article  Google Scholar 

  7. 7.

    Tomasi T, Sledz D, Wales JK, Recant L. Insulin half-life in normal and diabetic subjects. Exp Biol Med. 1967;126:315–7.

    CAS  Article  Google Scholar 

  8. 8.

    Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018;36:1817–24.

    Article  Google Scholar 

  9. 9.

    Fasching P, Roden M, Stühlinger HG, Kurzemann S, Zeiner A, Waldhäusl W, et al. Estimated glucose requirement following massive insulin overdose in a patient with type 1 diabetes. Diabet Med. 1994;11:323–5.

    CAS  Article  Google Scholar 

  10. 10.

    Mégarbane B, Deye N, Bloch V, Sonneville R, Collet C, Launay J-M, et al. Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles. Crit Care. 2007;11:R115.

    Article  Google Scholar 

  11. 11.

    Shibutani Y, Ogawa C. Suicidal insulin overdose in a type 1 diabetic patient: relation of serum insulin concentrations to the duration of hypoglycemia. J Diabetes Complications. 2000;14:60–2.

    CAS  Article  Google Scholar 

  12. 12.

    Holger JS, Stellpflug SJ, Cole JB, Harris CR, Engebretsen KM. High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock. Clin Toxicol. 2011;49:653–8.

    CAS  Article  Google Scholar 

Download references

Funding

There are no sources of funding.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Justin N. Corcoran.

Ethics declarations

Conflict of Interest

There are no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supervising Editor: Lewis S. Nelson, MD

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Corcoran, J.N., Jacoby, K.J., Olives, T.D. et al. In Reply: “On Insulin Kinetics Following High-Dose Insulin Therapy, and When to Stop Therapy”. J. Med. Toxicol. (2021). https://doi.org/10.1007/s13181-021-00829-4

Download citation